Singapore markets close in 5 hours 31 minutes
Straits Times Index
3,300.91 +7.98 (+0.24%) Nikkei
38,236.07 -38.03 (-0.10%) Hang Seng
18,471.02 -4.90 (-0.03%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
63,875.01 +694.67 (+1.10%) CMC Crypto 200
1,328.31 +51.33 (+4.02%)
SAB Biotherapeutics, Inc. (SABSW)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 0.0300 |
| Open | 0.0379 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.0300 - 0.0379 |
| 52-week range | 0.0300 - 0.0379 |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | 0.80 |
| PE ratio (TTM) | 0.13 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
SAB Biotherapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
SAB Biotherapeutics ( NASDAQ:SABS ) Full Year 2023 Results Key Financial Results Net loss: US$42.2m (loss widened by...
- Simply Wall St.
Individual investors are SAB Biotherapeutics, Inc.'s (NASDAQ:SABS) biggest owners and were rewarded after market cap rose by US$535m last week
Key Insights SAB Biotherapeutics' significant individual investors ownership suggests that the key decisions are...
© 2024 Yahoo. All rights reserved.